| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89874bbc6cfc9446b8a855b994deb274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90348a429ffa25bbd39a647ab0d9173e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b61a5dc92d507159d5fed306d643bbeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ea2dece696d54ecace086afb0b61af6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd9503a9fbacdd3542e2531aa0a1b7c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_363ebb0137a3338f1a071ddbfdc52d31 |
| publicationDate |
2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113521078-A |
| titleOfInvention |
Aged cell killing agent and application thereof |
| abstract |
The invention relates to an aged cell killing agent and application thereof, wherein the aged cell killing agent comprises apilimod or pharmaceutically acceptable salts, esters and solvates thereof. The invention discovers for the first time that the medicine Apilimod (Apilimod) has specific killing effect on aged cells, and the killing rate is more than 70 percent, so the medicine Apilimod can be used as a novel aged cell killing agent, and is more likely to be used as a potential novel anti-aging medicine because the medicine Apilimod can effectively eliminate the aged cells. |
| priorityDate |
2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |